TLDR Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.
The study investigated the effects of overexpressing human kallikrein 14 (KLK14) in transgenic mice (TghKLK14) and found significant hair shaft defects and abnormal epidermal differentiation. These defects were linked to the degradation of desmoglein 3 and 4, essential for cell adhesion in the epidermis. Additionally, the mice exhibited increased expression of inflammatory markers such as IL-36A and IL-17C, indicating an inflammatory response. The findings suggested that KLK14 played a critical role in hair and skin pathology, offering potential insights into conditions like Netherton Syndrome. The study included multiple experiments with at least four mice per genotype, ensuring robust data.
35 citations,
August 2009 in “Differentiation” Desmoglein 4 is controlled by specific proteins that affect hair growth.
50 citations,
February 2004 in “Genomics” A gene mutation causes lanceolate hair in rats by disrupting hair shaft integrity.
36 citations,
July 1996 in “The journal of investigative dermatology/Journal of investigative dermatology” Mice with the 'lanceolate hair' mutation have abnormal hair and skin similar to human Netherton's syndrome.
11 citations,
August 2013 in “International Journal of Cosmetic Science” The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.
5 citations,
October 2014 in “Methods” The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.
10 citations,
July 2015 in “Current opinion in pediatrics, with evaluated MEDLINE/Current opinion in pediatrics” New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.
21 citations,
July 2022 in “Orphanet journal of rare diseases” New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.
17 citations,
February 2015 in “Cell Death and Disease” Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.